TTK Healthcare Peer Comparison

TTK Healthcare Ltd. shows significant weaknesses in growth, profitability, and efficiency metrics compared to its peers, indicating a financially stressed position within the pharmaceuticals sector. With zero revenue and profit growth, and no returns on equity, the company may struggle to attract investors seeking profitable and growing businesses.

• • TTK Healthcare has zero revenue growth and profitability metrics, placing it at a disadvantage compared to peers.
• • Sun Pharmaceutical and Cipla are the strongest performers in terms of profitability and efficiency metrics.
• • TTK Healthcare's valuation ratios suggest it may be overvalued given its lack of performance.

• • Cipla Ltd.: Cipla demonstrates strong revenue growth (YoY), a solid EPS, and high ROE and ROCE, making it a leader in profitability.
• • Sun Pharmaceutical Industries: Despite high PE, Sun Pharma's strong growth metrics (8.42% YoY revenue growth) and profitability (ROE of 16.13%) make it a top performer.